Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Sep 24, 2024; 15(9): 1177-1187
Published online Sep 24, 2024. doi: 10.5306/wjco.v15.i9.1177
Published online Sep 24, 2024. doi: 10.5306/wjco.v15.i9.1177
Systematic treatment in gastric cancer patients with overt bleeding: A propensity score matching analysis
Yan-Hong Yao, Yu Xiao, Zhen-Tao Liu, Jin-Yu Yu, Qian Li, Bao-Shan Cao, Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China
Yan-Hong Yao, Bao-Shan Cao, Department of Cancer Center, Peking University Third Hospital, Beijing 100191, China
Hua Zhang, Yan-Yan Shi, Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, China
Author contributions: Cao BS and Yao YH conceived and designed the study; Yao YH, Liu ZT, Yu JY, Xiao Y and Li Q performed data collection; Yao YH and Zhang H performed statistical analysis; All the authors contributed to the data interpretation; Yao YH written the first draft of the manuscript; All the authors revised and edited the final manuscript.
Institutional review board statement: This study was approved by the Peking University Third Hospital Medical Science Research Ethics Committee (IRB00006761-M2023544).
Clinical trial registration statement: The study has been registered in clinicaltrials.gov. The registration identification number is NCT06522542.
Informed consent statement: A waiver of informed consent was granted by the Ethics Committee.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
Data sharing statement: The datasets analyzed during the study are available from the corresponding author on reasonable request.
CONSORT 2010 statement: The authors have read the CONSORT 2010 statement, and the manuscript was prepared and revised according to the CONSORT 2010 statement.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Bao-Shan Cao, MD, Chief Physician, Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, No. 49 North Garden Road, Haidian District, Beijing 100191, China. caobaoshan0711@aliyun.com
Received: March 22, 2024
Revised: July 12, 2024
Accepted: July 31, 2024
Published online: September 24, 2024
Processing time: 160 Days and 5 Hours
Revised: July 12, 2024
Accepted: July 31, 2024
Published online: September 24, 2024
Processing time: 160 Days and 5 Hours
Core Tip
Core Tip: Overt bleeding (OB) is a dangerous condition in patients with advanced or metastatic gastric cancer (GC)/gastroe